4376 - 4400 of 5898 Results
Title
Year
- Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI2017OPENTitle: Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRIJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 10Start Page: 2050End Page: 2080Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nprot.2017.081Best OA location URL: https://europepmc.org/articles/pmc6185898?pdf=renderCitation Count: 143
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://europepmc.org/articles/pmc6386531?pdf=renderCitation Count: 81
- Engineered Axonal Tracts as “Living Electrodes” for Synaptic‐Based Modulation of Neural Circuitry2017OPENTitle: Engineered Axonal Tracts as “Living Electrodes” for Synaptic‐Based Modulation of Neural CircuitryJournal Name: Advanced Functional MaterialsPublisher: WileyVol: 28Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1002/adfm.201701183Best OA location URL: https://rss.onlinelibrary.wiley.com/doi/am-pdf/10.1002/adfm.201701183Citation Count: 48
-
OPENTitle: Beyond L-DOPA: hope for Parkinson’s treatment and diagnosisJournal Name: EBioMedicinePublisher: Elsevier BVVol: 23Issue #:Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2017.09.009Best OA location URL: http://www.ebiomedicine.com/article/S2352396417303626/pdfCitation Count: 0
-
OPENTitle: Effects of small-molecule amyloid modulators on a Drosophila model of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 9Start Page: e0184117End Page: e0184117Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0184117Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0184117&type=printableCitation Count: 14
-
OPENTitle: α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic NeurodegenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 105Issue #:Start Page: 84End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.05.014Best OA location URL: https://europepmc.org/articles/pmc5701756?pdf=renderCitation Count: 142
-
OPENTitle: β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6354Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aaf3934Best OA location URL: https://science.sciencemag.org/content/sci/357/6354/891.full.pdfCitation Count: 386
-
OPENTitle: Clinicopathologic discrepancies in a population‐based incidence study of parkinsonism in olmsted county: 1991‐2010Journal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1439End Page: 1446Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27125Best OA location URL: https://europepmc.org/articles/pmc5931206?pdf=renderCitation Count: 23
-
OPENTitle: The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 88End Page: 98Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27105Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27105Citation Count: 490
-
OPENTitle: Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cellsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-10501-zBest OA location URL: https://www.nature.com/articles/s41598-017-10501-z.pdfCitation Count: 94
-
OPENTitle: The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 55Issue #: 6Start Page: 5125End Page: 5136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-017-0748-3Best OA location URL: https://kclpure.kcl.ac.uk/portal/files/78254338/Sanz_Blasco_et_al_2017.pdfCitation Count: 17
-
OPENTitle: The LRR-Roc-COR module of theChlorobium tepidumRoco protein: crystallization and X-ray crystallographic analysisJournal Name: Acta Crystallographica Section F Structural Biology CommunicationsPublisher: International Union of Crystallography (IUCr)Vol: 73Issue #: 9Start Page: 520End Page: 524Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1107/s2053230x17011955Best OA location URL: https://europepmc.org/articles/pmc5619744?pdf=renderCitation Count: 9
-
OPENTitle: Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharideJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 115End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.08.009Best OA location URL: https://europepmc.org/articles/pmc5734673?pdf=renderCitation Count: 54
-
OPENTitle: Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0935-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0935-1Citation Count: 82
-
OPENTitle: LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infectionJournal Name: Journal of Experimental MedicinePublisher: Rockefeller University PressVol: 214Issue #: 10Start Page: 3051End Page: 3066Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1084/jem.20170014Best OA location URL: https://rupress.org/jem/article-pdf/214/10/3051/1166015/jem_20170014.pdfCitation Count: 137
-
OPENTitle: GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 11Start Page: 1363End Page: 1368Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13395Best OA location URL: https://europepmc.org/articles/pmc5657539?pdf=renderCitation Count: 28
-
OPENTitle: The facial morphology in Down syndrome: A 3D comparison of patients with and without obstructive sleep apneaJournal Name: American Journal of Medical Genetics Part APublisher: WileyVol: 173Issue #: 11Start Page: 3013End Page: 3021Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ajmg.a.38399Best OA location URL: https://europepmc.org/articles/pmc5650534?pdf=renderCitation Count: 22
-
OPENTitle: Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free AssaysJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 126Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/55361Best OA location URL: https://www.jove.com/pdf/55361/recombinant-synucleins-stimulate-protein-phosphatase-2a-catalyticCitation Count: 7
-
OPENTitle: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging studyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 9Start Page: 632End Page: 639Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.438Best OA location URL: https://doi.org/10.1002/acn3.438Citation Count: 17
-
OPENTitle: LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson’s diseaseJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 26Issue #: 22Start Page: 4340End Page: 4351Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddx320Best OA location URL: https://academic.oup.com/hmg/article-pdf/26/22/4340/24339268/ddx320.pdfCitation Count: 84
-
OPENTitle: Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particlesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 8Start Page: e0181844End Page: e0181844Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0181844Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181844&type=printableCitation Count: 30
-
OPENTitle: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdfCitation Count: 24
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://europepmc.org/articles/pmc5664950?pdf=renderCitation Count: 0
-
OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Best OA location URL: https://europepmc.org/articles/pmc5831666?pdf=renderCitation Count: 674
-
OPENTitle: Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-017-07181-0Best OA location URL: https://www.nature.com/articles/s41598-017-07181-0.pdfCitation Count: 108